Page last updated: 2024-10-17

aminocaproic acid and Migraine Disorders

aminocaproic acid has been researched along with Migraine Disorders in 1 studies

Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.

Migraine Disorders: A class of disabling primary headache disorders, characterized by recurrent unilateral pulsatile headaches. The two major subtypes are common migraine (without aura) and classic migraine (with aura or neurological symptoms). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Zhu, J1
Pedersen, MD1
Ahmed, LS1
Abdolalizadeh, B1
Grell, AS1
Berg, JO1
Thulstrup, PW1
Franzyk, H1
Edvinsson, L1
Sams, A1
Sheykhzade, M1
Hansen, PR1

Other Studies

1 other study available for aminocaproic acid and Migraine Disorders

ArticleYear
Fluorescent Analogues of Human α-Calcitonin Gene-Related Peptide with Potent Vasodilator Activity.
    International journal of molecular sciences, 2020, Feb-17, Volume: 21, Issue:4

    Topics: Action Potentials; Aminocaproic Acid; Animals; Calcitonin Gene-Related Peptide; Circular Dichroism;

2020